| EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda S Aggarwal, S Negi, P Jha, PK Singh, T Stobdan, MAQ Pasha, S Ghosh, ... Proceedings of the National Academy of Sciences 107 (44), 18961-18966, 2010 | 197 | 2010 |
| Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease P Talwar, Y Silla, S Grover, M Gupta, R Agarwal, S Kushwaha, R Kukreti BMC genomics 15, 1-16, 2014 | 103 | 2014 |
| Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment M Gupta, P Bhatnagar, S Grover, H Kaur, R Baghel, Y Bhasin, C Chauhan, ... Future Medicine Ltd 10 (3), 385-397, 2009 | 97 | 2009 |
| HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis S Grover, R Kukreti Pharmacogenetics and genomics 24 (2), 94-112, 2014 | 93 | 2014 |
| Mendelian randomization S Grover, F Del Greco M, CM Stein, A Ziegler Statistical Human Genetics: Methods and Protocols, 581-628, 2017 | 74 | 2017 |
| Dissecting complex and multifactorial nature of Alzheimer’s disease pathogenesis: a clinical, genomic, and systems biology perspective P Talwar, J Sinha, S Grover, C Rawat, S Kushwaha, R Agarwal, V Taneja, ... Molecular neurobiology 53, 4833-4864, 2016 | 72 | 2016 |
| Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms M Gupta, C Chauhan, P Bhatnagar, S Gupta, S Grover, PK Singh, ... Future Medicine Ltd 10 (2), 277-291, 2009 | 62 | 2009 |
| Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients S Grover, K Bala, S Sharma, M Gourie-Devi, R Baghel, H Kaur, M Gupta, ... Biochimie 92 (9), 1207-1212, 2010 | 58 | 2010 |
| Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment S Grover, M Gourie-Devi, R Baghel, S Sharma, K Bala, M Gupta, ... Pharmacogenomics 11 (7), 927-941, 2010 | 52 | 2010 |
| A systematic review and meta‐analysis of the role of ABCC2 variants on drug response in patients with epilepsy S Grover, R Kukreti Epilepsia 54 (5), 936-945, 2013 | 48 | 2013 |
| Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease P Talwar, J Sinha, S Grover, R Agarwal, S Kushwaha, MVP Srivastava, ... Journal of the neurological sciences 360, 179-187, 2016 | 42 | 2016 |
| Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population AK Giri, NM Khan, S Grover, I Kaur, A Basu, N Tandon, V Scaria, ... Pharmacogenomics 15 (10), 1337-1354, 2014 | 38 | 2014 |
| Risky behaviors and Parkinson disease: A mendelian randomization study S Grover, CM Lill, M Kasten, C Klein, F Del Greco M, IR König Neurology 93 (15), e1412-e1424, 2019 | 36 | 2019 |
| Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs S Grover, M Gourie-Devi, K Bala, S Sharma, R Kukreti Pharmacogenetics and genomics 22 (6), 447-465, 2012 | 36 | 2012 |
| Genetic polymorphisms in sex hormone metabolizing genes and drug response in women with epilepsy S Grover, P Talwar, M Gourie-Devi, M Gupta, K Bala, S Sharma, R Baghel, ... Pharmacogenomics 11 (11), 1525-1534, 2010 | 36 | 2010 |
| Genetic architecture of Parkinson's disease in the Indian population: harnessing genetic diversity to address critical gaps in Parkinson's disease research R Rajan, KP Divya, RM Kandadai, R Yadav, VP Satagopam, ... Frontiers in neurology 11, 524, 2020 | 30 | 2020 |
| Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of … H Kaur, A Jajodia, S Grover, R Baghel, S Jain, R Kukreti American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 165 …, 2014 | 24 | 2014 |
| Multifactorial analysis of a biomarker pool for Alzheimer disease risk in a North Indian population P Talwar, S Grover, J Sinha, P Chandna, R Agarwal, S Kushwaha, ... Dementia and Geriatric Cognitive Disorders 44 (1-2), 25-34, 2017 | 22 | 2017 |
| Genetic contribution of CYP1A1 variant on treatment outcome in epilepsy patients: a functional and interethnic perspective P Talwar, N Kanojia, S Mahendru, R Baghel, S Grover, G Arora, ... The pharmacogenomics journal 17 (3), 242-251, 2017 | 22 | 2017 |
| Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients H Kaur, A Jajodia, S Grover, R Baghel, M Gupta, S Jain, R Kukreti PLoS One 9 (7), e102556, 2014 | 20 | 2014 |
Ritushree KukretiCSIR-Institute of genomics and integrative biologyVerified email at igib.in
